Las guas de la American Diabetes Association (ADA) recomiendan considerar estos agentes tempranamente en el algoritmo de tratamiento, particularmente en pacientes con enfermedad cardiovascular establecida o alto riesgo cardiovascular, dado que algunos agonistas de GLP-1 han demostrado reduccin de eventos cardiovasculares mayores en ensayos clnicos
40% of women with PCOS are obese and have a high BMI
PFAS was associated with certain targets, including albumin, peroxisome proliferator-activated receptor , and interleukin-10, and may influence lipid metabolism and atherosclerosis
Switching to Tirzepatide typically shows results within a few weeks
One of the most promising developments in the management of Irritable Bowel Syndrome (IBS) is the use of BPC-157, a peptide with significant potential for supporting gut health
Context-dependent regulation of ferroptosis sensitivity